Lepu Biopharma Co. Ltd. Class H Financial Overview
Lepu Biopharma Co. Ltd. Class H's market cap is currently HK$14.55B. The company's EPS TTM is HK$0.021862535; its P/E ratio is ―; Lepu Biopharma Co. Ltd. Class H is scheduled to report earnings on August 20, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Dec 21
Dec 20
Currency in CNY
Lepu Biopharma Co. Ltd. Class H Earnings and Revenue History
